(Q44584057)

4 December 2017

Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance (English)

1 reference

4 December 2017

0 references

1 reference

1 reference

3

Edward S Horton

1 reference

4 December 2017

Lais U Monzillo

1

1 reference

4 December 2017

Osama Hamdy

2

1 reference

4 December 2017

Sarah Ledbury

4

1 reference

4 December 2017

Cathy Mullooly

5

1 reference

4 December 2017

Catherine Jarema

6

1 reference

4 December 2017

Satoko Porter

7

1 reference

4 December 2017

Kerry Ovalle

8

1 reference

4 December 2017

Amr Moussa

9

1 reference

4 December 2017

Christos S Mantzoros

10

1 reference

4 December 2017

1 September 2003

1 reference

4 December 2017

1 reference

4 December 2017

11

1 reference

4 December 2017

1048-1054

1 reference

4 December 2017

9

1 reference

Medical hazards of obesity

4 December 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.144

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.144

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.144

Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.144

Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.144

Mechanisms of TNF-alpha-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.144

The hormone resistin links obesity to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.144

Resistin gene expression in human adipocytes is not related to insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.144

Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.144

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.144

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.144

Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.144

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.144

Effects of mild aerobic exercise and a mild hypocaloric diet on plasma leptin in sedentary women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.144

Leptin, insulin and TNF-alpha in weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.144

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.144

Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.144

Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.144

Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.144

The role of leptin in human obesity and disease: a review of current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.144

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.144

Decreasing levels of tumour necrosis factor alpha and interleukin 6 during lowering of body mass index with orlistat or placebo in obese subjects with cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.144

Changes in tumor necrosis factor-alpha system and insulin sensitivity during an exercise training program in obese women with normal and impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.144

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.144

Resistin - a mediator of obesity-associated insulin resistance or an innocent bystander?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.144

Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.144

Weight Reduction Increases Plasma Levels of an Adipose-Derived Anti-Inflammatory Protein, Adiponectin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.144

Tumor necrosis factor (TNF) inhibits interleukin (IL)-1 and/or IL-6 stimulated synthesis of C-reactive protein (CRP) and serum amyloid A (SAA) in primary cultures of human hepatocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.144

Tumor necrosis factor: function, release and clearance.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.144

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2003.144

1 reference

4 December 2017

1 reference